U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C23H33N2O
Molecular Weight 353.5209
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 1

SHOW SMILES / InChI
Structure of ISOPROPAMIDE

SMILES

CC(C)[N+](C)(CCC(C(N)=O)(C1=CC=CC=C1)C2=CC=CC=C2)C(C)C

InChI

InChIKey=JTPUMZTWMWIVPA-UHFFFAOYSA-O
InChI=1S/C23H32N2O/c1-18(2)25(5,19(3)4)17-16-23(22(24)26,20-12-8-6-9-13-20)21-14-10-7-11-15-21/h6-15,18-19H,16-17H2,1-5H3,(H-,24,26)/p+1

HIDE SMILES / InChI
Isopropamide is a quaternary ammonium antimuscarinic with peripheral effects similar to those of atropine. It has been used as an adjunct in the treatment of peptic ulcer disease, in the relief of gastro-intestinal and urinary tract disorders associated with smooth muscle spasm, in rhinitis, and the relief of symptoms of cold.

Originator

Curator's Comment: reference retrieved from http://www.drugfuture.com/chemdata/isopropamide-iodide.html

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
DARBID

Approved Use

Isopropamide (I) is a quaternary ammonium antimuscarinic with peripheral effects similar to those of atropine. It has been used as an adjunct in the treatment of peptic ulcer disease, in the relief of gastro-intestinal and urinary tract disorders associated with smooth muscle spasm, in rhinitis, and the relief of symptoms of cold.

Launch Date

-3.85948811E11
Primary
DARBID

Approved Use

Isopropamide (I) is a quaternary ammonium antimuscarinic with peripheral effects similar to those of atropine. It has been used as an adjunct in the treatment of peptic ulcer disease, in the relief of gastro-intestinal and urinary tract disorders associated with smooth muscle spasm, in rhinitis, and the relief of symptoms of cold.

Launch Date

-3.85948811E11
Doses

Doses

DosePopulationAdverse events​
40 mg single, oral (max)
MTD
Dose: 40 mg
Route: oral
Route: single
Dose: 40 mg
Sources: Page: p.537
unhealthy, 27-53
n = 7
Health Status: unhealthy
Condition: Duodenal ulcer
Age Group: 27-53
Sex: M+F
Population Size: 7
Sources: Page: p.537
PubMed

PubMed

TitleDatePubMed
Spectrophotometric determination of isopropamide iodide and trifluoperazine hydrochloride in presence of trifluoperazine oxidative degradate.
2010 Apr
Development of a list of potentially inappropriate drugs for the korean elderly using the delphi method.
2010 Dec
Patents

Sample Use Guides

Unknown
Route of Administration: Oral
In Vitro Use Guide
Unknown
Name Type Language
ISOPROPAMIDE
VANDF   WHO-DD  
Common Name English
ISOPROPAMIDE ION
Common Name English
BENZENEPROPANAMINIUM, .GAMMA.-(AMINOCARBONYL)-N-METHYL-N,N-BIS(1-METHYLETHYL)-.GAMMA.-PHENYL-
Systematic Name English
(3-CARBAMOYL-3,3-DIPHENYLPROPYL)DIISOPROPYLMETHYLAMMONIUM
Systematic Name English
ISOPROPAMIDE CATION
Common Name English
Isopropamide [WHO-DD]
Common Name English
ISOPROPAMIDE [VANDF]
Common Name English
Classification Tree Code System Code
CFR 21 CFR 520.1921
Created by admin on Fri Dec 15 16:14:43 UTC 2023 , Edited by admin on Fri Dec 15 16:14:43 UTC 2023
CFR 21 CFR 520.1920
Created by admin on Fri Dec 15 16:14:43 UTC 2023 , Edited by admin on Fri Dec 15 16:14:43 UTC 2023
WHO-ATC A03CA01
Created by admin on Fri Dec 15 16:14:43 UTC 2023 , Edited by admin on Fri Dec 15 16:14:43 UTC 2023
WHO-VATC QA03AB09
Created by admin on Fri Dec 15 16:14:43 UTC 2023 , Edited by admin on Fri Dec 15 16:14:43 UTC 2023
CFR 21 CFR 522.1920
Created by admin on Fri Dec 15 16:14:43 UTC 2023 , Edited by admin on Fri Dec 15 16:14:43 UTC 2023
WHO-ATC A03AB09
Created by admin on Fri Dec 15 16:14:43 UTC 2023 , Edited by admin on Fri Dec 15 16:14:43 UTC 2023
WHO-VATC QA03CA01
Created by admin on Fri Dec 15 16:14:43 UTC 2023 , Edited by admin on Fri Dec 15 16:14:43 UTC 2023
NCI_THESAURUS C66880
Created by admin on Fri Dec 15 16:14:43 UTC 2023 , Edited by admin on Fri Dec 15 16:14:43 UTC 2023
Code System Code Type Description
WIKIPEDIA
ISOPROPAMIDE
Created by admin on Fri Dec 15 16:14:43 UTC 2023 , Edited by admin on Fri Dec 15 16:14:43 UTC 2023
PRIMARY
EPA CompTox
DTXSID9023174
Created by admin on Fri Dec 15 16:14:43 UTC 2023 , Edited by admin on Fri Dec 15 16:14:43 UTC 2023
PRIMARY
NCI_THESAURUS
C73139
Created by admin on Fri Dec 15 16:14:43 UTC 2023 , Edited by admin on Fri Dec 15 16:14:43 UTC 2023
PRIMARY
RXCUI
89784
Created by admin on Fri Dec 15 16:14:43 UTC 2023 , Edited by admin on Fri Dec 15 16:14:43 UTC 2023
PRIMARY RxNorm
PUBCHEM
3775
Created by admin on Fri Dec 15 16:14:43 UTC 2023 , Edited by admin on Fri Dec 15 16:14:43 UTC 2023
PRIMARY
FDA UNII
8B9I31H724
Created by admin on Fri Dec 15 16:14:43 UTC 2023 , Edited by admin on Fri Dec 15 16:14:43 UTC 2023
PRIMARY
CAS
7492-32-2
Created by admin on Fri Dec 15 16:14:43 UTC 2023 , Edited by admin on Fri Dec 15 16:14:43 UTC 2023
PRIMARY
DRUG BANK
DB01625
Created by admin on Fri Dec 15 16:14:43 UTC 2023 , Edited by admin on Fri Dec 15 16:14:43 UTC 2023
PRIMARY
SMS_ID
100000086458
Created by admin on Fri Dec 15 16:14:43 UTC 2023 , Edited by admin on Fri Dec 15 16:14:43 UTC 2023
PRIMARY
DRUG CENTRAL
1500
Created by admin on Fri Dec 15 16:14:43 UTC 2023 , Edited by admin on Fri Dec 15 16:14:43 UTC 2023
PRIMARY
ECHA (EC/EINECS)
231-316-9
Created by admin on Fri Dec 15 16:14:43 UTC 2023 , Edited by admin on Fri Dec 15 16:14:43 UTC 2023
PRIMARY
EVMPD
SUB02799MIG
Created by admin on Fri Dec 15 16:14:43 UTC 2023 , Edited by admin on Fri Dec 15 16:14:43 UTC 2023
PRIMARY